WEP Clinical Acquires Netherlands-Based CRO Siron Clinical
January 14, 2026
WEP Clinical, a global contract research organization, has acquired Netherlands-based Siron Clinical to expand its European footprint and enhance Phase I–IV trial delivery capabilities. Siron — with offices in Belgium and Germany and a track record in orphan, pediatric, and medical device trials — will be integrated into WEP’s Clinical Trials division to broaden operational capacity and geographic reach.
- Buyers
- WEP Clinical
- Targets
- Siron Clinical
- Industry
- Healthcare Services
- Location
- Netherlands
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Worldwide Clinical Trials Acquires Catalyst Clinical Research
February 17, 2026
Healthcare Services
Worldwide Clinical Trials, a Kohlberg-backed contract research organization, has completed its acquisition of Nottingham-based oncology specialist Catalyst Clinical Research from QHP Capital. The deal expands Worldwide's early-phase oncology, biometrics, and functional service provider (FSP) capabilities, creating a combined organization of roughly 4,400 employees across more than 70 countries; financial terms were not disclosed.
-
The Jordan Company (Resolute V) Invests in WEP Group Holdings (WEP Clinical)
November 18, 2021
Healthcare Services
Affiliates of The Resolute Fund V, managed by The Jordan Company, completed an investment in WEP Group Holdings Limited (WEP Clinical), with co-founders Jaswinder and Jaswant Khera remaining significant owners. The capital will support WEP Clinical's organic and inorganic growth as it expands its expanded-access, distribution, pharmacovigilance and market-access services for drug developers worldwide.
-
P95 Acquires 4Clinics to Expand Global CRO Services
July 1, 2024
Healthcare Services
P95 BV, an Ampersand Capital Partners portfolio company, has acquired 4Clinics, a contract research organization providing data management, biostatistics, medical writing, regulatory affairs and clinical operations. The acquisition (effective July 1, 2024) integrates 4Clinics' team into the P95 group to strengthen CRO capabilities—particularly in biometrics and medical writing—and to enhance service coverage for Francophone clients.
-
Kohlberg Acquires Majority Stake in Worldwide Clinical Trials
August 7, 2023
Healthcare Services
An affiliate of Kohlberg & Company agreed to acquire a majority stake in Worldwide Clinical Trials, a global contract research organization (CRO) headquartered in Research Triangle Park, North Carolina. The transaction is a recapitalization in which prior investor TJC, L.P. retains a meaningful minority equity stake; terms were not disclosed. Kohlberg will partner with Worldwide's management (Matt Jennings to become chairman) to support continued growth of the company's clinical trial and bioanalytical capabilities.
-
P95 BV (Ampersand-backed) Merges South Africa CRO OnQ Research into P95
October 16, 2023
Healthcare Services
P95 BV, a vaccine-focused CRO and portfolio company of Ampersand Capital Partners, has signed an agreement to merge South Africa-based contract research organization OnQ Research into P95. The deal, structured as an add-on to P95, expands P95's presence across Africa and enhances its vaccine and infectious-disease clinical research and real-world evidence capabilities.
-
Altasciences Acquires WCCT Global
February 12, 2021
Healthcare Services
Altasciences acquired WCCT Global, an early‑stage clinical research organization (CRO) based in Southern California, expanding its West Coast clinical pharmacology capabilities and adding 180 clinical beds. The transaction, completed February 12, 2021, augments Altasciences’ Phase I/II services and expertise in specialized areas such as ethnobridging to support biopharmaceutical sponsors.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.